Shandong Luoxin Pharmaceutical Group is a Chinese publicly listed pharmaceutical company (Stock Code: 002793) that develops, manufactures, and commercializes its own branded pharmaceutical products. The company signs licensing agreements with international partners (Marinomed, JW Holdings, HK inno.N) for in-licensing drugs into the Chinese market. While it has 4 FDA-registered manufacturing sites with FDA-approved injectable products, it operates as a branded pharma company rather than a contract manufacturer.
branded pharmaceutical development, in-licensing of international drugs for China market, injectable manufacturing, P-CAB development
1 site worldwide
No reviews available yet.
No documents available.